Your browser doesn't support javascript.
loading
Caloric Restriction Improves Spatial Learning Deficits in Tau Mice.
Cogut, Valeria; McNeely, Taylor L; Bussian, Tyler J; Graves, Sara I; Baker, Darren J.
Afiliação
  • Cogut V; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
  • McNeely TL; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
  • Bussian TJ; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
  • Graves SI; Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA.
  • Baker DJ; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
J Alzheimers Dis ; 98(3): 925-940, 2024.
Article em En | MEDLINE | ID: mdl-38517786
ABSTRACT

Background:

Caloric restriction (CR) has been recognized for its benefits in delaying age-related diseases and extending lifespan. While its effects on amyloid pathology in Alzheimer's disease (AD) mouse models are well-documented, its effects on tauopathy, another hallmark of AD, are less explored.

Objective:

To assess the impact of a short-term 30% CR regimen on age-dependent spatial learning deficits and pathological features in a tauopathy mouse model.

Methods:

We subjected male PS19 tau P301S (hereafter PS19) and age-matched wildtype mice from two age cohorts (4.5 and 7.5 months old) to a 6-week 30% CR regimen. Spatial learning performance was assessed using the Barnes Maze test. Tau pathology, neuroinflammation, hippocampal cell proliferation, and neurogenesis were evaluated in the older cohort by immunohistochemical staining and RT-qPCR.

Results:

CR mitigated age-dependent spatial learning deficits in PS19 mice but exhibited limited effects on tau pathology and the associated neuroinflammation. Additionally, we found a decrease in hippocampal cell proliferation, predominantly of Iba1+ cells.

Conclusions:

Our findings reinforce the cognitive benefits conferred by CR despite its limited modulation of disease pathology. Given the pivotal role of microglia in tau-driven pathology, the observed reduction in Iba1+ cells under CR suggests potential therapeutic implications, particularly if CR would be introduced early in disease progression.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tauopatias / Doença de Alzheimer Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tauopatias / Doença de Alzheimer Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article